top of page

CAPABILITIES

EFFICACY MODELS

EFFICACY MODELS

Model list may be filtered by model type and organ
Filter items with Model Type
Filter items with Organ
Cell line
Organ
Model Type
Mutations
Weeks from stratification to termination (average)
22Rv1
Prostate
Xenograft
KMT2D, PIK3CA, TP53
5
4T1
Breast
Syngeneic
Unavailable
4
786-0
Renal
Xenograft
PTEN, TERT, TP53, VHL
N/A
A-375
Skin
Xenograft
BRAF, CDKN2A, TERT
4
A20
Blood
Syngeneic
Unavailable
N/A
A431
Skin
Xenograft
TP53, EGFR-PPARGC1A fussion
N/A
A498
Renal
Xenograft
PIK3CB, VHL
5
A549
Lung
Xenograft
KRAS, STK11, TP53
6
A673
Sarcoma
Xenograft
BRAF, TP53, EWS-FLI1 fusion
3
AB22
Lung
Syngeneic
CDKN2A
N/A
AGS
Gastric
Xenograft
CTNNB1, KRAS, PIK3CA, TP53
6
B16-F10
Skin
Syngeneic
Unavailable
2
BxPc-3
Pancreatic
Xenograft
BRAF, KRAS, TP53
7
CHLA-06
Brain
Xenograft
TP53
6
CT26
Colon
Syngeneic
KRAS
2.5
CT26.CL25
Colon
Syngeneic
KRAS
2.5
Caki-1
Renal
Xenograft
RB1
4
Cloudman S91
Skin
Syngeneic
Unavailable
N/A
Colo-205
Colon
Xenograft
APC, BRAF, CTNNB1, TP53
2.5
Colon-26 (MC26)
Colon
Syngeneic
Unavailable
4
D4M3A
Skin
Syngeneic
Unavailable
2
DLD-1
Colon
Xenograft
APC, ACVR2A, B2M, EP300, KRAS, PIK3CA, TGFBR2, TP53
4
DU-145
Prostate
Xenograft
CDKN2A, RB1, STK11, TP53
6
EMT6
Breast
Syngeneic
Unavailable
5
ES-2-luc
Ovarian
Xenograft
BRAF, PALB2, TERT, TP53
3.5
HCC1954
Breast
Xenograft
PIK3CA, TP53, CLTC-VMP1 fusion
7
HCT-116
Colon
Xenograft
ACVR2A, BRCA2, CDKN2A, CTNNB1, EP300, KRAS, PIK3CA, PPM1D, TGFBR2, TP53
5
HT-29
Colon
Xenograft
APC, BRAF, PIK3CA, SMAD4, TP53
N/A
HuCCT1
Bile Duct
Xenograft
KRAS, MSH6, TP53
5
Huh-7
Liver
Xenograft
KDR, POLD3, TERT, TP53
4
JIMT-1
Breast
Xenograft
PIK3CA, TP53
8
JeKo-1
Blood
Xenograft
TP53
5
LASCPC-01
Prostate
Xenograft
Unavailable
3
LNCaP
Prostate
Xenograft
AR, MEN1, PIK3R1, PTEN, TP53
4
Lewis Lung LLC1
Lung
Syngeneic
Unavailable
3
MBT-2
Bladder
Syngeneic
Unavailable
5.5
MC38
Colon
Syngeneic
Unavailable
4
MDA-MB-231
Breast
Xenograft
CDKN2A, CDKN2B, BRAF, KRAS, TERT, TP53
4
MDA-MB-468
Breast
Xenograft
PTEN, RB1, TP53
N/A
MIAPaCa-2
Pancreatic
Xenograft
KRAS, TP53
8
MOLM-13
Blood
Xenograft
FLT3, KMT2A-MLLT3 fusion
14
NCI-H1703
Lung
Xenograft
CDKN2A, TP53
3
NCI-H1975
Lung
Xenograft
EGFR, PIK3CA, TP53
6
NCI-H460
Lung
Xenograft
KRAS, PIK3CA, STK11, TP53
5
NCI-N87
Gastric
Xenograft
ERBB3, TP53
6
OCI-AML-3
Blood
Xenograft
DNMT3A, NRAS, NPM1
2
OCI-Ly1
Blood
Xenograft
Unavailable
N/A
OVCAR8
Ovarian
Xenograft
CTNNB1, ERBB2, KRAS, TP53
8
P388
Blood
Syngeneic
Unavailable
N/A
PANC-1
Pancreatic
Xenograft
KRAS, TP53
3
PC-3
Prostate
Xenograft
TP53
4
SK-BR-3
Breast
Xenograft
TP53
4
SK-N-FI
Brain
Xenograft
NF1, TP53
4
SK-N-MC
Sarcoma
Xenograft
TP53, EWS-FLI1 fusion
3
SK-OV-3
Ovarian
Xenograft
APC, FBXW7, PIK3CA, TP53
10
SKM-1
Blood
Xenograft
ASXL1, BCORL1, EZH2, KRAS, TP53
3
SU-DHL-16
Blood
Xenograft
Unavailable
4
SW480
Colon
Xenograft
APC, KRAS, TP53
4
TT
Thyroid
Xenograft
RET, TBX3
4
U-87MG
Brain
Xenograft
Unavailable
3
U118-MG
Brain
Xenograft
IDH1, PTEN, TP53
6
UM-UC-3
Bladder
Xenograft
KRAS, PARD3B, TERT, TP53
N/A
VcAP
Prostate
Xenograft
MLH1, TP53, TMPRss2-ERG fusion
N/A
WITT (SK-Cha-1)
Bile Duct
Xenograft
Unavailable
N/A
WM164
Skin
Xenograft
BRAF
6
YAPC
Pancreatic
Xenograft
KRAS, TP53
N/A
ADDITIONAL CAPABILITIES

ADDITIONAL CAPABILITIES

  • ​Fluorescent and luminescent imaging

  • Pharmacokinetic studies

  • MTD and tolerability studies

  • Tumor and organ collection

  • Histology and animal pathology

  • Pharmacodynamic assays, including ELISA, Mesoscale/Luminex, PCR, flow cytometry, and sequencing

  • Complementary cell-based in vitro assays supporting in vivo studies​​

 

Need something outside the standard study design? Talk to us. 

WHY WORK WITH

RINCON BIO?

DOMESTIC QUALITY.  EXCEPTIONAL VALUE. 

 

Rincon conducts studies at our U.S. facilities. Your work stays close, your IP stays protected, and communication stays direct. We bring the depth of expertise you’d expect from a major CRO without the administrative layers and overhead, so more of your budget goes directly toward the science.

SPEED TO INITIATION
 

Most studies initiate within two business days

DIRECT ACCESS

 

Work directly with the PhD running your study—not a rotating account manager. We stay responsive, flexible, and hands-on throughout the study.

Please fill out a form to receive a quote within 1 business day

Contact Us

Email: info@rinconbio.com
Tel:  760-713-6613

​

Utah: 

3900 N Traverse Mountain Blvd

Suite 100

Lehi, UT 84043

​

California: 

3156 Vista Way, Suite 220

Oceanside, CA 92056

 

CONTACT US
bottom of page